Ying Feng
Second Affiliated Hospital of Guangzhou Medical University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Blood groups and transfusion, Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia(2021)71 cited
- → High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial(2020)59 cited
- → 1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China(2019)31 cited
- → A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation(2018)30 cited
- → Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study(2017)22 cited
- → Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study